key: cord-0427199-ntmme5cy authors: Matthies, A.; Trauer, M.; Chopra, K.; Jarman, R. title: Diagnostic accuracy of point-of-care lung ultrasound for COVID-19: A systematic review and meta-analysis date: 2021-10-11 journal: nan DOI: 10.1101/2021.10.09.21264799 sha: 49fc6c2d84fb66c4c6631afa07c260a9bc4702da doc_id: 427199 cord_uid: ntmme5cy Background. Point-of-care (POC) lung ultrasound (LUS) is widely used in the emergency setting and there is an established evidence base across a range of respiratory diseases, including previous viral epidemics. The necessity for rapid testing combined with the limitations of other diagnostic tests has led to the proposal of various potential roles for LUS during the COVID-19 pandemic. This systematic review and meta-analysis focused specifically on the diagnostic accuracy of LUS in adult patients presenting with suspected COVID-19. Methods. Traditional and grey-literature searches were performed on June 1st 2021. Two authors independently carried out the searches, selected studies and completed the Quality Assessment Tool for Diagnostic Test Accuracy Studies (QUADAS-2). Meta-analysis was carried out using established open-source packages in R. We report overall sensitivity, specificity, positive and negative predictive values and the hierarchical summary receiver operating characteristic curve for LUS. Heterogeneity was determined using the I2 statistic. Results. Twenty studies were included, providing data from a total of 4,314 patients. The prevalence and admission rates were generally high across all studies. Overall LUS was found to be 87.2% sensitive (95% CI 83.6-90.2) and 69.5% specific (95% CI 62.2-72.5) and demonstrated overall positive and negative predictive values of 3.0 (95% 2.3-4.1) and 0.16 (95% 0.12-0.22) respectively. Separate analyses for each reference standard revealed similar sensitivities and specificities for LUS. Heterogeneity between studies was found to be high, and QUADAS-2 assessment identified risks of bias in many studies. Conclusion. During a period of high prevalence, LUS is a highly sensitive diagnostic test for COVID-19. However, more research is required to confirm these results in more generalisable populations, including those less likely to be admitted to hospital. Emergency) protocol was found to be greater than 90% accurate for the underlying diagnosis of acute respiratory distress. Since then, there has been a proliferation of research into LUS which has confirmed that it is highly accurate for several respiratory conditions and often more accurate than chest radiograph (CXR). (3, 4) The utility of LUS has also been described during previous viral epidemics. LUS was found to be accurate in differentiating viral and bacterial pneumonia during the influenza epidemic in 2009 and was found to be more accurate than CXR for avian flu. (5, 6) Furthermore, CXR and a single initial reverse transcriptase polymerase chain reaction (RT-PCR) test have both been shown to have sub-optimal diagnostic accuracy for COVID-19. In a large meta-analysis, CXR was found to be 81% sensitive and 72% specific. (7) A single initial RT-PCR test has also been found to have a sensitivity as low as 71% when compared to serial testing.(8) Whilst chest Computed Tomography (CT) has been shown to be more accurate than CXR (7) , this is neither an appropriate nor feasible test to provide for every patient, and is not recommended by the Royal College of Radiologists. (9) the potential to reduce nosocomial infections and healthcare provider exposure to . (15) The sonographic findings of COVID-19 pneumonitis (or pneumonia) are now well described and include pleural line abnormalities, B-lines and consolidation. The constellation of findings is also well understood with abnormalities typically bilateral and patchy. (16) A scoping review of the diagnostic utility of LUS in COVID-19 was published in August 2020, yielding 33 studies. The methodology of the included studies was generally poor and only 5 studies reported diagnostic accuracy. However, there was a trend towards high sensitivity and low specificity. (17) Since then, we have experienced second and third waves of infection, and further evidence concerning the role of LUS has accumulated. The purpose of this systematic review was to evaluate the diagnostic accuracy of POC LUS in adult patients presenting with suspected COVID-19 infection compared to three commonly used reference standards used for the diagnosis of COVID-19; 1) RT-PCR, 2) chest CT, 3) Aggregate final clinical diagnosis. . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. This systematic review was synthesised according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses(18), and the protocol was registered on PROSPERO (CRD42021250464). No funding was sought for the production of this work. Traditional sources of literature were searched, including Ovid MEDLINE, Embase, SCOPUS, Cochrane Library and Google Scholar. Less traditional sources were also searched including medRxiv, the pre-print server for health sciences. A search strategy was developed in line with existing guidance(19) and searches were performed on June 1 st 2021 (see supplementary material 1). . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.09.21264799 doi: medRxiv preprint All prospective and retrospective trials of patients over 16 years of age comparing lung ultrasonography to either RT-PCR, chest CT, or a final clinical diagnosis of COVID-19 were included. Case reports, editorials and recommendation/instructional journal papers were excluded. Searches were carried out independently by two reviewers (AM, MT), with disagreements reviewed by a third reviewer (RJ). A screening and selection tool (see supplementary material 2) was agreed upon and applied to identify eligible studies from both the abstract and subsequent full-text review. The reference lists from these studies were also reviewed to identify and further relevant studies. Multiple scanning protocols have been described and the specific threshold of findings necessary to diagnose COVID-19 has also not been agreed upon. Studies were included regardless of the number of zones scanned or the diagnostic threshold used. Although a positive RT-PCR is recognised as the Gold Standard diagnostic test for ruling-in COVID-19 infection, it is less reliable at ruling-out the disease. Whilst RT-PCR testing is used to detect infection LUS is used to diagnose viral pneumonia. Chest CT has been described as the reference standard for viral pneumonia (20) but is infrequently used in clinical practice. An alternative to both is the use of a final clinical diagnosis incorporating imaging findings and results of serial RT-PCR tests. We have included studies using all three reference standards, and present combined and individual data. Two independent reviewers (AM, MT) extracted the following data (displayed in is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; as a measure of disease severity), prevalence of COVID-19, sensitivity, specificity, number of true positive and negative results, number of false positive and negative results, scanning technique and diagnostic threshold (or scoring) for LUS, reference test and blinding. Disagreements were resolved by a third independent reviewer (RJ). Two reviewers (AM, MT) independently used the Quality Assessment Tool for Diagnostic Test Accuracy Studies (QUADAS-2) to evaluate the quality of each study and risk of bias. Disagreements were resolved by a third independent reviewer (RJ). Data was analysed using a dedicated application, MetaDTA (Complex Reviews is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. Our search identified 3041 studies from traditional databases and registers, and 221 from other sources. Following removal of duplicates, eligibility screening by title/abstract and then full-text review a total of 20 studies were included. A flow chart was produced in line with the PRISMA guidelines ( Figure 2 ). shown in Table 1 . A total of 4,314 patients were included. There was an even mix of prospective (n = 11) and retrospective (n = 9) studies, and all were convenience samples. The prevalence of COVID-19 infection ranged from 12% to 75%. Thirteen studies used RT-PCR as the reference test, whilst five used chest CT and three the final clinical diagnosis. The smallest study included 43 patients whilst the largest included 1462. Sensitivity of LUS ranged between 68% and 100% and specificity ranged between 21% and 97%. (11) (12) (13) (14) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) Comparison to RT-PCR testing. Fifteen studies used RT-PCR as the reference standard. In this group, sensitivity ranged between 68% and 96% whilst specificity ranged between 21% and 91%. (11, 12, 14, (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) This included the largest study published study which included 1462 patients, and classified patients according to their clinical phenotype: 1) Mild (without dyspnoea or respiratory failure); 2) Severe (with dyspnoea or respiratory failure); and 3) Mixed is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; sensitivity of chest CT ranged between 69% and 90%. Both LUS and CT were far less specific than RT-PCR. (28, 31, 32) . Three studies also found LUS to be more sensitive than CXR. (11, 12, 35) In one study, the authors compared traditional clinical evaluation to an integrated assessment incorporating POC LUS. Clinical examination was found to be 81% sensitive and 64% specific whereas integrated assessment with LUS was 94% sensitive and 95% specific. Two studies adopted scoring systems for the LUS findings. Unsurprisingly those who tested positive on RT-PCR had higher scores (optimal cut-off scores are shown in Table 1 ). (25, 26) . It was also demonstrated that complete (12-zone) studies were 5% more sensitive and 4% more specific than less thorough studies. (26) Comparison to chest CT. Five studies (a total of 282 patients) used chest CT as the reference standard. Sensitivity ranged between 65% and 97% and specificity between 59% and 97%. (13, 27, 34, 36, 37) In one of these studies, LUS was also compared to CXR and found to be more sensitive and similarly specific. (36) Comparison to final clinical diagnosis. Three studies used a final clinical diagnosis as the reference standard (a total of 347 patients). Sensitivity of LUS ranged between 85% and 91% and specificity between 75% and 80%. (31, 38, 39) Two studies adopted scoring systems for LUS and optimal cut-off scores demonstrating sensitivities above 90% and specificities above 75%. (39) Combining all studies, LUS had an overall sensitivity of 87.2% (95% CI 83. 6-90.2) and specificity of 69.5% (62.2-72.5). Forest plots for each are shown in Figure 3a . Positive and negative likelihood ratios were 3.04 (2.27-4.06) and 0.16 (0.12-0. 22) respectively. The HSROC curve is shown in Figure 4 . Heterogeneity between all . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; studies was high, with I 2 values of 71.6% (95% CI 58.7-91. 5 The results of the QUADAS-2 assessment are shown in Table 2 . Overall, most studies were deemed high risk for bias. Convenience sampling and the use of certain exclusion criteria introduced a risk of selection bias in all studies. There were also applicability concerns, with most studies conducted during a period of high disease prevalence and including predominantly patients requiring hospital admission. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Reports not retrieved (n = 0) Reports assessed for eligibility (n = 34) Reports excluded: Only conference proceeding available (n =1) Did not meet study eligibility criteria (n = 13) Duplicate record (n = 1) Records identified from: Websites including medRxiv preprint server (n = 221) Reports assessed for eligibility (n = 221) Reports excluded: 220 Duplicate study/data (n = 1) Did not meet study eligibility criteria (n = 219) Reports of included studies (n = 1) Reports sought for retrieval (n = 221) Reports not retrieved (n = 0) No details provided. Images over-interpreted by 3 fellowship trained physicians. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.09.21264799 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; Table 2 . QUADAS-2 assessment (J Low risk, L High risk, ? Unclear risk). Studies arranged by sample size, from largest. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; disease prevalence can be useful measures of the performance of a diagnostic test. This is an important consideration given the overall high prevalence rates reported in the studies. In an era of relatively lower prevalence, the PPV of LUS may be significantly lower than has been estimated. Caution should therefore be taken when considering the application of LUS for early diagnosis, screening and cohorting patients in the setting of lower prevalence. There is a rapidly expanding evidence base demonstrating favourable characteristics for molecular and other non-RT-PCR tests for COVID-19 that are much easier and faster to perform and can turn over rapid results.(8) The availability of these tests will likely impact on the value of LUS as an early bedside clinical tool. Integrated LUS, used in combination with other clinical data, may also improve early diagnostic accuracy in the ED. Walsh et al showed that both sensitivity and specificity were increased when LUS was integrated with clinical findings as opposed to interpreted in isolation. (13) The potential to integrate bedside imaging findings is unique to POCUS and may enhance diagnostic accuracy. This concept was exemplified by Pivetta et al when they showed that an integrated LUS approach was highly accurate in patients with acute decompensated heart failure, more so than CXR or B-natriuretic peptide levels. (4) All but three studies adopted a comprehensive 12-zone LUS technique. Given that the changes observed in viral pneumonia are bilateral and patchy, scanning technique is likely to affect sensitivity. Various scanning techniques have been described ranging from only limited views of the anterior chest to a more thorough examination of each intercostal space both anteriorly and posteriorly. Brenner et al, showed that when only complete 12-zone studies were included in their analysis, both sensitivity and specificity of LUS were improved. (26) The heterogenous criteria used to determine whether a positive LUS may also have affected the results of the various. Various thresholds were used for ruling in this diagnosis, ranging from any B lines to a minimum number of affected zones to a minimum severity score. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Lower diagnostic thresholds generally favoured improved sensitivity whilst higher thresholds favoured specificity. Whilst relatively common in COVID-19 pneumonia, B-lines are also commonly seen in multiple respiratory diseases. (2) Intuitively, a low diagnostic threshold (for example, the presence of any B-lines) is likely to be sensitive but non-specific. Data presented by Volpicelli et al suggests that a diagnostic score weighted to the specific sonographic findings is likely to be more useful than a binary cut-off. (14) We therefore propose the development of a diagnostic (as opposed to severity) scoring system. Such a system could quantify the likelihood of COVID-19 depending on how typical the LUS features were for COVID-19. A resulting estimated likelihood ratio could then be integrated with a pretest probability to provide the treating clinician with a post-test probability. The overall quality of studies was low, with internal validity affected by convenience sampling and the external validity by patient selection concerns. Furthermore, several studies reported data from small samples and provided no prior sample size estimates. There was significant variation in the LUS protocols used as well as the diagnostic threshold for a positive scan. Furthermore, there was some variability regarding the prior experience and training of the operators. POCUS is an operator-dependent technique where a single provider is responsible for both image acquisition and interpretation. Therefore, both the specific training received and prior experience of the scanning physicians is likely to influence diagnostic accuracy. Future research should focus on wider populations, including mildly and asymptomatic patients, during periods of lower disease prevalence to define the role and setting in which LUS is most useful. As previously described, future work is required to define the optimal diagnostic threshold for LUS. Finally, further work is required to understand the training and experience required to gain proficiency in LUS. . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.09.21264799 doi: medRxiv preprint LUS was found to be highly sensitive in a population of both high prevalence and mostly admitted patients and may improve detection of COVID-19 pneumonia in this group compared to CXR. In hypoxic patients requiring admission, a normal LUS should prompt consideration of an alternative diagnosis. Although overall specificity was less optimal, the presence of a full spectrum or typical pattern of LUS findings is likely to be more specific and as such a quantitative diagnostic LUS scoring system is likely to be more useful than a binary threshold. WHO) WHO. Coronavirus disease (COVID-19) dashboard International evidence-based recommendations for point-of-care lung ultrasound Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol Lung ultrasound integrated with clinical assessment for the diagnosis of acute decompensated heart failure in the emergency department: a randomized controlled trial Prospective application of clinicianperformed lung ultrasonography during the 2009 H1N1 influenza A pandemic: distinguishing viral from bacterial pneumonia Lung ultrasonography for the diagnosis of 11 patients with acute respiratory distress syndrome due to bird flu H7N9 infection The role of CT in patients with COVID-19 infection, Statement of the Royal College of Radiologists Is There a Role for Lung Ultrasound During the COVID-19 Pandemic? The role of lung ultrasound as a frontline diagnostic tool in the era of COVID-19 outbreak Point-ofcare Lung Ultrasound Is More Sensitive than Chest Radiograph for Evaluation of COVID-19 Point-of-care Lung Ultrasound Is Useful to Evaluate Emergency Department Patients for COVID-19 Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19 Sonographic signs and patterns of COVID-19 The utility of lung ultrasound in COVID-19: A systematic scoping review Diagnostic Accuracy of Chest Radiograph, and When Concomitantly Studied Lung Ultrasound, in Critically Ill Patients With Respiratory Symptoms: A Systematic Review and Meta-Analysis Development of an interactive web-based tool to conduct and interrogate metaanalysis of diagnostic test accuracy studies: MetaDTA Diagnostic test accuracy: application and practice using R software Conducting Meta-Analyses in R with the metafor Package Point-of-care ultrasound (PoCUS) in the early diagnosis of novel coronavirus 2019 disease (COVID-19) in a first-level emergency department during a SARS-CoV-2 outbreak in Italy: a real-life analysis Lung ultrasound as diagnostic tool for SARS-CoV-2 infection Diagnostic accuracy of lung ultrasound for SARS-CoV-2: a retrospective cohort study Diagnostic accuracy of point-of-care lung ultrasound in COVID-19 Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence Lung ultrasound in early SARS-CoV-2 pneumonia and the LUS-CoV criteria Diagnosing COVID-19 pneumonia in a pandemic setting: Lung Ultrasound versus CT (LUVCT) -a multicentre, prospective, observational study Feasibility of using point-of-care lung ultrasound for early triage of COVID-19 patients in the emergency room Lung Ultrasonography for the Diagnosis of SARS-CoV-2 Pneumonia in the Emergency Department Lung ultrasound in the emergency department -a valuable tool in the management of patients presenting with respiratory symptoms during the SARS-CoV-2 pandemic Point-of-care ultrasonography in the initial characterization of patients with COVID-19 Lung Ultrasound vs. Chest X-Ray Study for the Radiographic Diagnosis of COVID-19 Pneumonia in a High-Prevalence Population Accuracy of Bedside Lung Ultrasound as a Rapid Triage Tool for Suspected Covid-19 Cases Lung Assessment with Point-of-Care Ultrasound in Respiratory Coronavirus Disease (COVID-19): A Prospective Cohort Study Lung' or 'Chest' or 'Thorax' or 'Thoracic' or 'Pulmonary' 2. 'Ultrasound' or 'Ultrasonography' or "Sonography' or 'Sonographic' or 'Ultrasonic' 3. 'COVID' or 'COVID-19' or 'Coronavirus' or ' Remove duplicates from '4' Searches of traditional databases and registers were undertaken using the following key terms and strategy: The following screening and selection tool was used by two independent reviewers during abstract and full-text review.